Cargando…

Optimized dual therapy for treatment‐naive patients of Helicobacter pylori infection: A large‐scale prospective, multicenter, open‐label, randomized controlled study

BACKGROUND: The efficacy and safety of high‐dose amoxicillin (AMX) and proton pump inhibitors (PPI) dual therapy raises much more attention in recent years. Comparative studies among the dual therapies are required to explore more suitable regimens. This study compared the efficacy, adverse events,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Ying‐Ying, Long, Hui, Lin, Ya, He, Qiong, Chen, Wei‐Gang, Ding, Xiang‐Wu, Zhou, Lin, An, Ping, Wang, Fen, Zhang, Zhen‐Yu, Hu, Yun‐Lian, Li, Pei‐Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541209/ https://www.ncbi.nlm.nih.gov/pubmed/35939559 http://dx.doi.org/10.1111/hel.12922

Ejemplares similares

The Application of High-Dose Proton Pump Inhibitor Induction Treatment before Dual Therapy for Helicobacter pylori Eradication: An Open-Label Random Trial
por: Chen, Li-Wei, et al.
Publicado: (2021)

Berberine containing quadruple therapy for initial Helicobacter pylori eradication: An open-label randomized phase IV trial
por: Zhang, Di, et al.
Publicado: (2017)

Dual therapy for Helicobacter pylori infection
por: Duan, Miao, et al.
Publicado: (2023)

Improving the quality of the esophagogastroduodenoscopy in Helicobacter pylori-naïve gastric cancer
por: Park, Jae Myung
Publicado: (2023)

The efficacy of vonoprazan combined with different dose amoxicillin on eradication of Helicobacter pylori: an open, multicenter, randomized clinical study
por: Lin, Yimin, et al.
Publicado: (2022)

Genomic features of Helicobacter pylori‐naïve diffuse‐type gastric cancer
por: Namikawa, Ken, et al.
Publicado: (2022)

The influence of gastric atrophy on Helicobacter pylori antibiotics resistance in therapy-naïve patients
por: Goni, Elisabetta, et al.
Publicado: (2022)

Histopathological Features of Helicobacter pylori Infection in Gastric Mucosa
por: Wang, Yang-Kun, et al.
Publicado: (2022)

From inflammation to gastric cancer: Role of Helicobacter pylori
por: Zhang, Xiao-Ying, et al.
Publicado: (2017)

Evaluation of Anti-Helicobacter pylori IgG Antibodies for the Detection of Helicobacter pylori Infection in Different Populations
por: Yu, Jin-Han, et al.
Publicado: (2022)

Addition of Nitazoxanide to Standard Clarithromycin Based Triple Therapy for 2 Weeks Effectively Eradicates Treatment-Naive Helicobacter Pylori Infection. A Single Centre prospective, open-label study
por: Jha, Sanjeev K., et al.
Publicado: (2022)

Fourth-generation quinolones in the treatment of Helicobacter pylori infection: A meta-analysis
por: An, Ying, et al.
Publicado: (2018)

Fourteen-day vonoprazan and low- or high-dose amoxicillin dual therapy for eradicating Helicobacter pylori infection: A prospective, open-labeled, randomized non-inferiority clinical study
por: Hu, Yi, et al.
Publicado: (2023)

Ilaprazole-amoxicillin dual therapy at high dose as a first-line treatment for helicobacter pylori infection in Hainan: a single-center, open-label, noninferiority, randomized controlled trial
por: Zhang, Xiao-Dong, et al.
Publicado: (2023)

Camrelizumab Plus Apatinib in Treatment-Naive Patients With Advanced Nonsquamous NSCLC: A Multicenter, Open-Label, Single-Arm, Phase 2 Trial
por: Ren, Shengxiang, et al.
Publicado: (2022)

Tocilizumab in treatment-naïve patients with Takayasu arteritis: TOCITAKA French prospective multicenter open-labeled trial
por: Mekinian, Arsene, et al.
Publicado: (2020)

Helicobacter pylori and Systemic Disease
por: Kuo, Chao-Hung, et al.
Publicado: (2014)

Helicobacter pylori
por: Harris, A. W. (Adam W.), 1963-
Publicado: (1996)

Helicobacter Pylori
por: Aguilar Lasserre, Rubén
Publicado: (1998)

Efficacy and safety of high-dose esomeprazole–amoxicillin dual therapy for Helicobacter pylori rescue treatment: a multicenter, prospective, randomized, controlled trial
por: Bi, Hanxin, et al.
Publicado: (2022)

Non-pylori Helicobacters (NHPHs) Induce Shifts in Gastric Microbiota in Helicobacter pylori-Infected Patients
por: Peng, Xianhui, et al.
Publicado: (2017)

Maintenance of the Cell Morphology by MinC in Helicobacter pylori
por: Chiou, Pei-Yu, et al.
Publicado: (2013)

Vonoprazan on the Eradication of Helicobacter pylori Infection
por: Huang, Jiaming, et al.
Publicado: (2023)

Helicobacter pylori Infection and Anemia in Taiwanese Adults
por: Shih, Hsiang-Yao, et al.
Publicado: (2013)

Rescue therapy with rifabutin regimen for refractory Helicobacter pylori infection with dual drug-resistant strains
por: Kuo, Chia-Jung, et al.
Publicado: (2020)

Antibiotic resistance profile of Helicobacter pylori to 14 antibiotics: a multicenter study in Fujian, China
por: Huang, Xueping, et al.
Publicado: (2023)

Outer Membrane Vesicles of Helicobacter pylori 7.13 as Adjuvants Promote Protective Efficacy Against Helicobacter pylori Infection
por: Song, Zifan, et al.
Publicado: (2020)

Probiotic Lactobacillus spp. Act Against Helicobacter pylori-induced Inflammation
por: Chen, Yi-Hsing, et al.
Publicado: (2019)

Helicobacter pylori infection with atrophic gastritis: An independent risk factor for colorectal adenomas
por: Chen, Qin-Fen, et al.
Publicado: (2020)

Evodiamine Inhibits Helicobacter pylori Growth and Helicobacter pylori-Induced Inflammation
por: Yang, Ji Yeong, et al.
Publicado: (2021)

Prevalence of Helicobacter pylori in HIV-infected, HAART-naïve Ugandan children: a hospital-based survey
por: Hestvik, Elin, et al.
Publicado: (2011)

Clinical efficacy of the modified Helicobacter pylori eradication therapy for Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: a meta analysis
por: Xie, Ya-Lin, et al.
Publicado: (2020)

Modified quadruple therapy versus bismuth-containing quadruple therapy in first-line treatment of Helicobacter pylori infection in Korea; rationale and design of an open-label, multicenter, randomized controlled trial
por: Lim, Hyun, et al.
Publicado: (2018)

Helicobacter pylori : revisión bibliográfica
por: Gómez Morayta, Enrique
Publicado: (2003)

An Overview of Helicobacter pylori Survival Tactics in the Hostile Human Stomach Environment
por: Cheok, Yi Ying, et al.
Publicado: (2021)

The impact of Helicobacter pylori infection, eradication therapy and probiotic supplementation on gut microenvironment homeostasis: An open-label, randomized clinical trial
por: Chen, Luyi, et al.
Publicado: (2018)

The efficacy and safety of Clostridium butyricum and Bacillus coagulans in Helicobacter pylori eradication treatment: An open-label, single-arm pilot study
por: Zhang, Jian, et al.
Publicado: (2020)

Eradication of Helicobacter pylori Is Associated with the Progression of Dementia: A Population-Based Study
por: Chang, Yang-Pei, et al.
Publicado: (2013)

Helicobacter pylori infection and primary open-angle glaucoma: is there a connection?
por: Tsolaki, Fani, et al.
Publicado: (2012)

Helicobacter pylori infection, dementia and primary open-angle glaucoma: are they connected?
por: Tsolaki, Fani, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fpggimb6nghfh979l33o9d1hom